Welcome to BioMarket Group!

Seasonal Influenza Vaccines Market Forecast

Additional Information

Published Date Aug 6, 2009
Special Offer No
Pages #N/A
PDF Fact Sheet View Fact Sheet for the report Seasonal Influenza Vaccines Market Forecast in PDF format.
Published on Date No
Format Interactive Model
Publisher Datamonitor
Product Line No
Full Title No

Availability: In stock

$15,200.00

Quick Overview

Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals.
Request free sample pages from Seasonal Influenza Vaccines Market Forecast

Introduction

Fuelled by the pandemic flu threat, the influenza market has expanded rapidly in recent years. This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals. The H1N1 pandemic will stimulate further growth, but also confronts industry and public health stakeholders with new challenges.

Reasons to Purchase

*Review the clinical and commercial factors driving new product decisions in influenza vaccines and the strategies of key players in the market

*Size the market with patient-based scenario forecasts of the seasonal vaccines market and a thorough analysis of the vaccine and antiviral pipeline

*Understand concerns, unmet needs and future opportunities in influenza prevention and therapy

Request free sample pages from Seasonal Influenza Vaccines Market Forecast

Other selected research from the 'Markets' category:


OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
Datamonitor’s OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) OTC Pharmaceuticals industry... Learn More


Obesity Market Forecast
The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, reluctant payers, and a clinical community that puts more stock in diet and exercise. Learn More

Other selected research from the 'Vaccines' category:


Cancer Vaccines Fantasy or Future?
In this newly updated progress analysis, BioSeeker not only provide a solid background and information structure, we also bring the latest within cancer vaccine achievements. Learn More


Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness
The development of therapeutic vaccines has expanded beyond cancer indications and is attracting increasing interest from Pharma and Biotech, driven by potential advantages such as improved specificity, long-lasting immune... Learn More